Literature DB >> 27868012

PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma.

Emma J de Ruiter1, Stefan M Willems1.   

Abstract

Entities:  

Year:  2016        PMID： 27868012      PMCID： PMC5104593          DOI： 10.21037/atm.2016.10.19

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  11 in total

1.  Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Authors:  K Kian Ang; Qiang Zhang; David I Rosenthal; Phuc Felix Nguyen-Tan; Eric J Sherman; Randal S Weber; James M Galvin; James A Bonner; Jonathan Harris; Adel K El-Naggar; Maura L Gillison; Richard C Jordan; Andre A Konski; Wade L Thorstad; Andy Trotti; Jonathan J Beitler; Adam S Garden; William J Spanos; Sue S Yom; Rita S Axelrod
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 2.  Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.

Authors:  David Murdoch
Journal:  Curr Opin Oncol       Date:  2007-05       Impact factor: 3.645

Review 3.  Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.

Authors:  Thomas J Ow; Casey E Pitts; Rafi Kabarriti; Madhur K Garg
Journal:  Arch Pathol Lab Med       Date:  2015-06-05       Impact factor: 5.534

4.  Enhanced radiation sensitivity in HPV-positive head and neck cancer.

Authors:  Randall J Kimple; Molly A Smith; Grace C Blitzer; Alexandra D Torres; Joshua A Martin; Robert Z Yang; Chimera R Peet; Laurel D Lorenz; Kwangok P Nickel; Aloysius J Klingelhutz; Paul F Lambert; Paul M Harari
Journal:  Cancer Res       Date:  2013-06-07       Impact factor: 12.701

Review 5.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

6.  Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.

Authors:  Walter Gregory Roberts; Ethan Ung; Pamela Whalen; Beth Cooper; Catherine Hulford; Christofer Autry; Daniel Richter; Earling Emerson; Jing Lin; John Kath; Kevin Coleman; Lili Yao; Luis Martinez-Alsina; Marianne Lorenzen; Martin Berliner; Michael Luzzio; Nandini Patel; Erika Schmitt; Susan LaGreca; Jitesh Jani; Matt Wessel; Eric Marr; Matt Griffor; Felix Vajdos
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 7.  Head and neck cancer.

Authors:  Athanassios Argiris; Michalis V Karamouzis; David Raben; Robert L Ferris
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

8.  Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.

Authors:  Heath D Skinner; Uma Giri; Liang Yang; Sang Hyeok Woo; Michael D Story; Curtis R Pickering; Lauren A Byers; Michelle D Williams; Adel El-Naggar; Jing Wang; Lixia Diao; Li Shen; You Hong Fan; David P Molkentine; Beth M Beadle; Raymond E Meyn; Jeffrey N Myers; John V Heymach
Journal:  Clin Cancer Res       Date:  2016-04-01       Impact factor: 12.531

Review 9.  Focal adhesion kinase as a potential target in oncology.

Authors:  Gordon W McLean; Egle Avizienyte; Margaret C Frame
Journal:  Expert Opin Pharmacother       Date:  2003-02       Impact factor: 3.889

Review 10.  Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.

Authors:  Justin E Swartz; Ajit J Pothen; Inge Stegeman; Stefan M Willems; Wilko Grolman
Journal:  Cancer Med       Date:  2015-04-27       Impact factor: 4.452
View more
  1 in total

1.  IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.

Authors:  Christine E Lehman; Adam Spencer; Sarah Hall; Jeremy J P Shaw; Julia Wulfkuhle; Emanuel F Petricoin; Stefan Bekiranov; Mark J Jameson; Daniel Gioeli
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.